1315 Capital II, L.P.
SEC insider (Form 3/4/5 filer). CIK 0001730825. 10% Owner at INTERPACE BIOSCIENCES, INC. (IDXG). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 20, 2026. Located in PARSIPPANY, NJ.
Companies 1315 Capital II, L.P. has filed insider reports for
- INTERPACE BIOSCIENCES, INC. (IDXG): 10% Owner
1315 Capital II, L.P.
CIK: 0001730825
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IDXG
INTERPACE BIOSCIENCES, INC.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 20, 2026IDXG
INTERPACE BIOSCIENCES, INC.
ConversionDirect9.4M shares at avg. $2.02$19.0M - Oct 11, 2024IDXG
INTERPACE BIOSCIENCES, INC.
DispositionIndirectSeries B Convertible Preferred Stock
19K shares- - Oct 11, 2024IDXG
INTERPACE BIOSCIENCES, INC.
AwardIndirectSeries C Convertible Preferred Stock
19K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 20, 2026 | IDXG INTERPACE BIOSCIENCES, INC. | Conversion | 9,405,941 | $2.02 | $19,000,001 | Direct |
| Oct 11, 2024 | IDXG INTERPACE BIOSCIENCES, INC. | Disposition Series B Convertible Preferred Stock | 19,000 | - | - | Indirect |
| Oct 11, 2024 | IDXG INTERPACE BIOSCIENCES, INC. | Award Series C Convertible Preferred Stock | 19,000 | - | - | Indirect |
1-3 of 3 transactions